Olanzapine And Fluoxetine Capsule
Product Images NDC 0093-5506

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olanzapine And Fluoxetine (NDC 0093-5506). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olanzapine Structure (Image 1)

Chemical structure of olanzapine, USP, showing its molecular composition with labeled atoms and bonds, as part of a pharmaceutical product containing olanzapine and fluoxetine.*

FDA Label Image

Fluoxetine Structure (Image 2)

Chemical structure of fluoxetine hydrochloride, USP, showing its molecular arrangement including a trifluoromethyl group attached to a benzene ring, an ether linkage, and a methylamine side chain with a hydrochloride salt.*

FDA Label Image

Figure01 (Image 3)

A line graph showing the proportion of patients with relapse over time (days) from randomization. It compares two treatments: Fluoxetine (dashed line) and Olanzapine and Fluoxetine (solid line), displaying lower relapse proportions for the combination treatment throughout the study period up to 240 days.*

FDA Label Image

Image (Image 4)

Label for Olanzapine and Fluoxetine Capsules USP, 3 mg/25 mg, manufactured by Teva Pharmaceuticals USA, Inc. The label includes dosage form as capsules, NDC 0093-5503-56, package count of 30 capsules, and storage instructions. It also contains a section instructing pharmacists to dispense the Medication Guide with the medication.*

FDA Label Image

Image (Image 5)

Label for Olanzapine and Fluoxetine Capsules USP 6 mg/25 mg by Teva Pharmaceuticals USA, Inc. The label indicates a 30-capsule bottle, prescription only, with storage instructions and a note to dispense the accompanying medication guide. The NDC number 0093-5504-56 is shown along with manufacturing and packaging details.*

FDA Label Image

Image (Image 6)

Label for Olanzapine and Fluoxetine Capsules USP with a strength of 6 mg/50 mg, manufactured by Teva Pharmaceuticals USA, Inc. The label includes the NDC 0093-5505-56, dosage form as capsules, and container size of 30 capsules. It also provides storage instructions, a barcode, and pharmacist dispensing information.*

FDA Label Image

Image (Image 7)

Label for Olanzapine and Fluoxetine Capsules USP 12 mg/25 mg by Teva Pharmaceuticals USA, Inc. The label includes a barcode, NDC number 0093-5506-56, and instructions for storage and handling. The package contains 30 capsules, with a note for pharmacists to dispense the medication guide. The label also states "Rx only."*

FDA Label Image

Image (Image 8)

Label for Olanzapine and Fluoxetine Capsules USP 12 mg/50 mg by Teva Pharmaceuticals USA, Inc. The label shows the NDC 0093-5507-56 and indicates the package contains 30 capsules. It includes storage instructions, a bar code, pharmacist dispensing note, and a lot/expiration area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.